The client previously purchased ISAB's aerosol generation platform PreciseInhale[®], in November 2020, plus two in vivo exposure modules. PreciseInhale[®] and its suite of advanced exposure modules can generate voluminous high-precision data through all phases of preclinical research, from in vitro to in vivo, from even tiny amounts of test substance.

Now the Department is complementing its PreciseInhale[®] suite with ISAB's advanced 3D cell exposure module XposeALI[®] for a total order value of 62 000 Euros. Unlike previous cell exposure systems - where cells are immersed in a liquid - XposeALI[®] enables the study of the permeability of substances in an Air-Liquid Interface - a more physiological approach that mimics the conditions and processes occurring in the lungs.

ISAB CEO Manoush Masarrat: "We're very pleased that the expert team at the University of Vienna are now complementing their PreciseInhale[® ]system with our unique cell exposure module XposeALI[®]. This is a purchase that shows clearly the advanced precision and capabilities of our equipment - and how it can grow and keep delivering to research teams and organizations to meet all their inhalation research needs."

To read more about XposeALI[®] go here. (https://www.inhalation.se/products/xposeali-cell-exposures/)